Combogesic Tablet, Film Coated
NDC Package 72260-129-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Combogesic (acetaminophen and ibuprofen) tablets is cOMBOGESIC and is indicated in adults for the short-term management of mild to moderate acute pain. This formulation utilizes a tablet, film coated delivery system. Marketed by Aft Pharmaceuticals Us, Inc., this product is identified by NDC 72260-129 and is authorized under FDA application NDA209471.

Identification & Billing

NDC Package Code
72260-129-01
Package Description
250 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Product Code
72260-129
11-Digit Billing Format
72260012901
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
250 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Combogesic
Non-Proprietary Name
Acetaminophen And Ibuprofen
Substance Name
Acetaminophen; Ibuprofen
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
COMBOGESIC and is indicated in adults for the short-term management of mild to moderate acute pain.

Regulatory & Marketing

Labeler Name
Aft Pharmaceuticals Us, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA209471
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-06-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72260-129-01 identifies a specific commercial package of 250 tablet, film coated in 1 bottle, plastic of Combogesic, a human prescription drug labeled by Aft Pharmaceuticals Us, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 250 billable units per package. This tablet, film coated is formulated for oral use and contains acetaminophen; ibuprofen as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aft Pharmaceuticals Us, Inc. on January 06, 2025. The current certification is valid through December 31, 2026.

How is this Aft Pharmaceuticals Us, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72260012901. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 250 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72260-129-01
11-Digit CMS (5-4-2)
72260-0129-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.